alexa Intra-articular Injection Of Botulinum Toxin Analgesic Effect
ISSN: 2161-0533

Orthopedic & Muscular System: Current Research
Open Access

Like us on:
OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations

700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Share This Page

Additional Info

Loading
Loading Please wait..
 

3rd International Conference and Exhibition on Orthopedics & Rheumatology
July 28-30, 2014 DoubleTree by Hilton Hotel San Francisco Airport, USA

Dominique Batifol
ScientificTracks Abstracts: Orthop Muscul Syst
DOI: 10.4172/2161-0533.S1.016
Abstract
Initiated in the author?s department in 2007, a prospective study on the usefulness of Botulinum Toxin (BT) in the treatment of algid dysfunction of the temporo-mandibular joint is still ongoing today. Results of treatment usually attempted in this form of pathology, excluding surgery were confronted. Following the work of Mahowald et al., it was decided to inject 30 U Botox* (Allergan Pharmaceuticals, Westport, Ireland) in each articulation using the standard aseptic technique under local anesthesia. Comparison with placebo was not done, knowing that buffered saline has a therapeutic effect. It was chosen to correlate with physiotherapy, medications, dental groove, intra-muscular injections of botulinum toxin and intra-articular injections of hyaluronic acid. Release or decrease of pain was the only goal of the injection. It was measured by visual analogical scale (VAS). For inclusion pain must be greater than 5/10, with all other treatments, excluding surgery, failing to provide any improvement. Currently, there are 56 patients in thestudy.VAS: 0/10 at one month in 26 patients (46 %), some of them presenting a VAS=10/10 prior to injection. VAS between 2 and 4/10 in 17 patients (30%). 13 patients (24%) showing no quantifiable improvement. Mechanism of BT action on pain has been studied for over ten years. BT seems to block the transmission of pain information. It is well tolerated, with reasonable costs and an easy technique. The action is merely analgesic.The results are encouraging, but must be confirmed by a multi-center randomized study.
Biography
Dominique Batifol graduated in 1986 as a Medical Doctor, specialized in maxillo-facial surgery and oral surgery at the University of Montpellier, France. She worked in private practice until 2002 and since then she has been working in the Department of Maxillo-Facial Surgery at the University Hospital of Montpellier (France), working exclusively on Botulinum toxin injections. She has 12 publications on her name.
image PDF   |   image HTML
 
Peer Reviewed Journals
 
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
 
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

 
© 2008-2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version
adwords